Ertugliflozin L-pyroglutamic acid
Ertugliflozin L-pyroglutamic acid (PF-04971729) is a potent and selective oral inhibitor of the human sodium-glucose cotransporter 2 (hSGLT2), exhibiting an IC50 of 0.877 nM. It is a research compound used in both in vitro and in vivo studies for investigating potential treatments for type 2 diabetes mellitus.
Product Specifications
CAS Number
1210344-83-4
Product Name Alternative
Inhibitor, h-SGLT2, hSGLT2, Ertugliflozin L pyroglutamic acid, Ertugliflozin Lpyroglutamic acid, Ertugliflozin L-pyroglutamic acid, inhibit, SGLT, PF-04971729 L-pyroglutamic acid, Sodium-dependent glucose cotransporters
Field of Research
Pharmacology & Drug Discovery
Purity
98.71% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (7.07 mM) ; DMSO:125 mg/mL (220.85 mM)
Smiles
OC (=O) [C@@H]1CCC (=O) N1.CCOc1ccc (Cc2cc (ccc2Cl) [C@]23OC[C@] (CO) (O2) [C@@H] (O) [C@H] (O) [C@H]3O) cc1
Molecular Formula
C27H32ClNO10
Molecular Weight
566
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1657505 3x 1.0 µg
PKN2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
25794061 1.0 µg DNA
KLHL30 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details